Most Therapeutics Letters analyze evidence to draw conclusions about average drug effects in defined groups of people. This Letter takes a clinical pharmacological approach to review how individuals may be harmed by dopamine (DA) receptor...
Dopamine receptor antagonists are a broad class of drugs characterized by their ability to interfere with the natural actions of the neurotransmitter dopamine, typically in brain, but also in the anterior pituitary where dopamine suppresses...
This live webinar has already taken place. Scroll down to view the video recording. --- The vast majority of meta-analyses published in medical journals use the I-squared (I2) statistic to quantify heterogeneity. While this use of I2 is...
Greg Carney, Jason D Kim, Cait O'Sullivan, Wade Thompson, Ken Bassett, Josh Levin, Colin R Dormuth. Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada. BMJ Open Diabetes Research and Care 2022;10:e002995. DOI: 10.1136/bmjdrc-2022-002995 Abstract Introduction Several new oral drug classes for...